- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
ALNY Market Currents
more »
-
May 3 Alnylam Pharma (ALNY): Q1 EPS of -$0.25 beats by $0.10. Revenue of $20.6M (-0.4% Y/Y) beats by $1M. (PR)
Comment![Earnings, Healthcare]
ALNY in Focus
more »
ALNY Related Articles
more »
ALNY News
more »
-
at MarketWatch.com (Feb 16, 2012)
-
at MarketWatch.com (Feb 15, 2012)
-
at MarketWatch.com (Feb 14, 2012)
-
at CNBC.com (Feb 14, 2012)
-
at CNBC.com (Jan 3, 2012)
ALNY Press Releases and Filings
more »
-
Business Wire (Wed, 8:00AM)
-
Business Wire (May 10, 2012)
-
Business Wire (May 9, 2012)
-
Business Wire (May 3, 2012)
-
Business Wire (Apr 26, 2012)
ALNY Latest Transcript
more »
-
Wed, Nov 3, 2010
ALNY Cramer
more »
ALNY Instablog posts
more »
ALNY vs. ETF Alternatives
Company Description
Currently, there's no company description for ALNY.
